Trials / Completed
CompletedNCT00322231
A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)
A Phase III Clinical Trial to Study the Safety, Tolerability and Immunogenicity of Zoster Vaccine Live in Subjects With a History of Herpes Zoster
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether the investigational zoster vaccine, is generally well tolerated when administered to participants with a history of herpes zoster.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | zoster vaccine live (ZOSTAVAX™) | 1 dose 0.65 mL/dose subcutaneous injection of zoster vaccine live |
| BIOLOGICAL | Comparator: Placebo | 1 dose 0.65 mL/dose subcutaneous injection of placebo. |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2007-07-01
- Completion
- 2007-07-01
- First posted
- 2006-05-05
- Last updated
- 2015-01-26
- Results posted
- 2010-12-15
Source: ClinicalTrials.gov record NCT00322231. Inclusion in this directory is not an endorsement.